Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Dow
Merck
UBS
Accenture
Boehringer Ingelheim
Cantor Fitzgerald
Healthtrust
AstraZeneca

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 010012

« Back to Dashboard

NDA 010012 describes SANDRIL, which is a drug marketed by Lilly and is included in two NDAs. Additional details are available on the SANDRIL profile page.

The generic ingredient in SANDRIL is reserpine. There are nineteen drug master file entries for this compound. Additional details are available on the reserpine profile page.
Summary for 010012
Tradename:SANDRIL
Applicant:Lilly
Ingredient:reserpine
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 010012

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength2.5MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Boehringer Ingelheim
Queensland Health
Johnson and Johnson
Julphar
Covington
Deloitte
McKinsey
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.